• Psychometric Properties and Measurement Equivalence of the English and Chinese Versions of the Beck Anxiety Inventory in Patients with Breast Cancer

    Nov 1, 2016, 00:00

  • Differences in Long-Term Patient Outcomes with Disease-Modifying Versus Symptomatic Treatments for Alzheimer’s Disease (Ad)

    Nov 1, 2016, 00:00

  • Quality of Life in Relapsing Remmiting Multiple Sclerosis- Influence of Interferon Beta-1a (Avonex And Cinnovex) Treatment

    Nov 1, 2016, 00:00

  • A Cost Comparison of 1l Treatment Regimens for Metastatic Colorectal Cancer (MCRC) in Italy

    Nov 1, 2016, 00:00

  • Tyrosine Kinase Inhibitors (TKI) For The Treatment of Advanced Medullary Thyroid Carcinoma- A Systematic Review and Indirect Comparison

    Nov 1, 2016, 00:00

  • The Health Economic Impact of Managing CMPA According To Guidelines- Challenging Current Treatment Practise In The UK

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Screening Strategies for Atrial Fibrillation in England and Wales

    Nov 1, 2016, 00:00

  • Cost-Analysis for Toxicity Management in Advanced Squamous Non-Small Cell Lung Cancer- Nivolumab vs Docetaxel

    Nov 1, 2016, 00:00

  • Primary Non-Adherence, Early Non-Persistence, Treatment Reinitiation and Long-Term Adherence Among A Population-Based Cohort of Naïve Patients Prescribed Antiosteoporotics

    Nov 1, 2016, 00:00

  • Association Between Body Mass Index Categories, Prevalence of Treated Type 2 Diabetes Mellitus, Total Healthcare Costs Among Patients Who Are Overweight or Obese

    Nov 1, 2016, 00:00

  • Access To Orphan Drugs In Poland - Is Change In Health Technology Assessment Approach Required?

    Nov 1, 2016, 00:00

  • Are treatment sequences, adverse events, long-term disease progression adequately considered in cost-effectiveness analyses of rheumatoid arthritis ?- A critical economic litterature review

    Nov 1, 2016, 00:00

  • Patient Characteristics And Outcomes Of Hospitalization For Influenza Infection In Hong Kong

    Nov 1, 2016, 00:00

  • Treatment of Hypertension in Elderly - Pharmacoeconomic Evaluation

    Nov 1, 2016, 00:00

  • Spinal Cord Stimulation Versus Conventional Medical Management for Failed Back Surgery Syndrome- A Dutch Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • How Beneficial Is Hrqol Assessment In The Course Of Treatment Decisions In Physical Rehabilitation? Results Of Clinicians' Perspective

    Nov 1, 2016, 00:00

  • Efficacy of Palbociclib Combinations Versus Endocrine Therapies in Advanced/ Metastatic Breast Cancer- Network Meta-Analysis

    Nov 1, 2016, 00:00

  • A Cprd-Hes Database Study of Back Pain in the UK- Patient Pathways

    Nov 1, 2016, 00:00

  • Economic Evaluation of Cervical Cancer Screening Strategies in China

    Nov 1, 2016, 00:00

  • Hcv Treatment with Daas in the ‘Real-World’- How Well Do ‘Real’ Patients Respond? The Irish Perspective

    Nov 1, 2016, 00:00

  • Systematic Review of Budget Impact Analysis on Vaccines

    Nov 1, 2016, 00:00

  • Health- Related Quality of Life in Diabetic People with Different Cardiovascular Risks

    Nov 1, 2016, 00:00

  • Macro-Economic Considerations in Healthcare Decision Making

    Nov 1, 2016, 00:00

  • The Guardians' Choices And Preferences For Imported Surrogate Vaccines In China- Based On A Survey In Shenyang, Liaoning Province

    Nov 1, 2016, 00:00

  • Using Social Finance to Fund Generic Drug Repurposing for Rare Diseases- A Social Impact Bond Proof of Concept

    Nov 1, 2016, 00:00

  • Role of Genetic Variation in Type Repeats of Histidine Rich Protein-2 Gene in Altering the Performance of Malaria Rapid Detection Kit in Global Context

    Nov 1, 2016, 00:00

  • Assessing The Cost-Utility of Etelcalcetide- A Markov Model

    Nov 1, 2016, 00:00

  • A Review Of The Quality And Accuracy Of Budget Impact Models For High Cost Drugs In Ireland

    Nov 1, 2016, 00:00

  • Assessment Of Core Drug Use Indicators Using Who/Inrud Methodology At Primary Health Care Centers In Bahawalpur, Pakistan

    Nov 1, 2016, 00:00

  • Ticagrelor Treatment for Prevention of Cardiovascular Events in High Risk Post Myocardial Infarction Patients- Cost-Effectiveness Analysis Using Evidence From The Pegasus-Timi 54 Trial

    Nov 1, 2016, 00:00

  • Requirements for Economic Evidence Across Different HTA Bodies

    Nov 1, 2016, 00:00

  • Antineoplastic Drug Expenditure in Panama 2012-2014

    Nov 1, 2016, 00:00

  • Adherence to Oral Antidiabetic Medication in Type 2 Diabetes Mellitus Clients in the Volta Region of Ghana

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Definitive Therapy- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • The Impact of Pharmacist Intervention on Medication Errors In A Teaching Hospital Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Defining Real-World Product Performance Using Survival Analysis and Superivsed Machine Learning

    Nov 1, 2016, 00:00

  • Is There a Threshold in France?- First Exhaustive Review of Published Health-Economic Appraisals by the Haute Autorite De Sante (HAS), (French National Authority for Health)

    Nov 1, 2016, 00:00

  • Impact of Surgical Technique on Length Of Stay and Early Outcomes in Breast Reconstruction- A Preliminary Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sucroferric Oxyhydroxide in Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Predicting Length Of Stay After Road Traffic Accident Accounting For Competing Endpoints With Time-Dependent Variables

    Nov 1, 2016, 00:00

  • Comparing the Hospitalization and Rehospitalization Expenditures of Myocardial Infarction Patients in Beijing, 2012-2013

    Nov 1, 2016, 00:00

  • The Economic Burden of Myocardial Infarction in Latin America

    Nov 1, 2016, 00:00

  • Comparison of Caregiver-Rated 3-Level Euroqol-5d (Eq-5d-3l) and Health Utilities Index Mark 3 (Hui3) in Patients with Dementia in Singapore

    Nov 1, 2016, 00:00

  • Advanced Therapies- Widening The Gap Between Payers And Regulators

    Nov 1, 2016, 00:00

  • Pharmaceutical Policies In Eurasian Economic Union Countries

    Nov 1, 2016, 00:00

  • Real World Evidence In Decision-Making Processes On Public Funding Of Drugs In Poland

    Nov 1, 2016, 00:00

  • Assessing Health-Utility Values for Chronic Spontaneous/Idiopathic Urticaria In Real-World Using The EQ-5D- Results From Assure-Csu Study

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation is Associated with Phase of Chronic Myeloid Leukaemia (CML)- Results of a Clinical Expert Survey in England and Wales

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness Threshold in Cancer Therapy – is This A Good Idea?

    Nov 1, 2016, 00:00

  • Attitudes Adherence and Barriers Among Puplicly Employed GPS Towards Evidence Based Medicine and Clinical Practice Guidelines in Cyprus

    Nov 1, 2016, 00:00

  • Value of Individually Prepared Drugs for Health System

    Nov 1, 2016, 00:00

  • Epidemiology of Patients Receiving Hematopoietic Stem Cell Patients in Belgium

    Nov 1, 2016, 00:00

  • Cost Of Illness Of Partial Onset Seizures Epilepsy In Italy- Results From The Prometeo Study

    Nov 1, 2016, 00:00

  • Predictive Validity of National Nosocomial Infection Surveillance (NNIS) and Study on the Efficacy of Nosocomial Infections (SENIC) Risk Indexes for the Incidence of Surgical Site Infections (SSI) in General Surgery at Hospital Universiti S ...

    Nov 1, 2016, 00:00

  • Analysis of Pharmacy Claims for High Cost Oncology Products- Abiraterone and Enzalutamide Usage in Mcrpc in Ireland

    Nov 1, 2016, 00:00

  • Evaluation of The Economic Impact of Ferric Carboxymaltose Use For The French National Health Insurance And The French Hospitals Organization

    Nov 1, 2016, 00:00

  • The Potential Budget Impact of PCSK9 Inhibitors in Ireland

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Paritaprevir/Rotanavir/Ombitasvir with or without Dasabuvir in Ireland

    Nov 1, 2016, 00:00

  • Reconsidering EQ-5D; Quality of Life Domains that are Important for Multiple Sclerosis Patients

    Nov 1, 2016, 00:00

  • Association Between Disease Prevalence, Drug Price and ASMR for Orphan Drugs in France

    Nov 1, 2016, 00:00

  • Assessment of Channelling Bias Among Initiators of Glucose Lowering Drugs - A Cohort Study

    Nov 1, 2016, 00:00

  • Assessment of Decisions and Cost-Effectiveness Criteria Considered by Seven Health Technology Assessment Agencies

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation Study of Sildenafil in a Tertiary Care Teaching Hospital in India – A Retrospective Analysis

    Nov 1, 2016, 00:00

  • Development and Evaluation of Patient Information Leaflets for Diabetic Foot Ulcer Patients

    Nov 1, 2016, 00:00

  • Epidemiological Profile of Knee Arthroplasty Surgery in Health Care System of Public Employees Located in Northeast Brazil Between July 2014 and December 2015

    Nov 1, 2016, 00:00

  • French Health Policies- Front Runner for Early Access to Innovation

    Nov 1, 2016, 00:00

  • Association Between Subjective Well-Being and Health Status Among the Elderly in China- The Influences of Social Support and Social Adjustment

    Nov 1, 2016, 00:00

  • The Cost Of Treating Mucormycosis With Isavuconazole Compared With Liposomal Amphotericin B Followed By Posaconazole In The United Kingdom- Economic Evaluation Of The Phase Iii Vital Study And Fungiscope Matched Case-Control Analysis

    Nov 1, 2016, 00:00

  • Delays In Breast Cancer Diagnosis And Initiation of Treatment- Implementing The Pathways To Treatment Model In The Greek Setting

    Nov 1, 2016, 00:00

  • Automation Of Hospital Medication Distribution Systems In The Us

    Nov 1, 2016, 00:00

  • Prevalence of Low Birthweight and its Correlates from 2008 to 2014 in Xindu County of Chengdu, China

    Nov 1, 2016, 00:00

  • Hemoglobin A1C (A1C) Reduction And Diabetes-Related Health Care Costs Among Type 2 Diabetes (T2DM) Patients Treated With Liraglutide or Exenatide- A Retrospective Claims Database Analysis

    Nov 1, 2016, 00:00

  • Risk Sharing Agreements (RSA)- Exploratory Analysis of the Current Situation in Developed and Emerging Markets

    Nov 1, 2016, 00:00

  • Economic And Humanistic Burden of Chronic Spontaneous Urticaria In Brazil- Impact on Work Productivity, Resource Utilization And Quality of Life

    Nov 1, 2016, 00:00

  • Progression and Outcomes of Non-Dialysis Dependent Chronic Kidney Disease Patients

    Nov 1, 2016, 00:00

  • Developing A Small Cell Lung Cancer Conceptual Model to Inform Treatment Outcome and Assessment Strategy Decisions in Clinical Research

    Nov 1, 2016, 00:00

  • Cost-Utility of In-Ambulance Telemedicine for Stroke Patients

    Nov 1, 2016, 00:00

  • How To Define Relevant Comparators In France? An Analysis Of The Economic Evaluations Submitted By Manufacturers And Reviewed By The Economic Committee (Ceesp) Of The French National Health Authority

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Blue-Light Therapy Vs Fixed Combination of Calcipotriol and Betamethasone Dipropionate Gel in the Treatment of Mild-To-Moderate Psoriasis

    Nov 1, 2016, 00:00

  • The Use Of Pharmacoeconomic Evidence To Encourage Generic Medicines Use In Jordan- A Cost Minimization Analysis

    Nov 1, 2016, 00:00

  • Burden of Congenital Hyperinsulinism In The United Kingdom- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • Market Potential Of A New Infliximab Biosimilar In The European Market- A Budget Impact Analysis In France, Italy And The Uk

    Nov 1, 2016, 00:00

  • The Clinical Value of Olmesartan for the Treatment of Hypertensive Patients- A Systematic Review

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of The Introduction Of Darunavir 800 Mg Qd For The 2nd Line Treatment Of Hiv-Infected Treatment-Experienced Adults On The Brazilian National Hiv Program

    Nov 1, 2016, 00:00

  • An Australian National Cost of Illness Study For Hereditary Haemochromatosis

    Nov 1, 2016, 00:00

  • Cost And Cost Per Responder In Spain of Adalimumab, Methotrexate And Apremilast In The Treatment of Methotrexate-Naïve Patients With Psoriatic Arthritis

    Nov 1, 2016, 00:00

  • Real World Experience of Sunitinib in Patients with Metastatic Renal Cell Carcinoma; Results from Compassionate use Program in Malaysia

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Treatment of Adult Patients with Severe Uncontrolled Asthma with Omalizumab In Russia

    Nov 1, 2016, 00:00

  • Theatre Efficiency and Effectiveness- NHS Trust and Industry Partnership

    Nov 1, 2016, 00:00

  • Resource use and Associated Costs for Metastatic Squamous Non-Small Cell Lung Cancer (SQ NSCLC) Patients- A Retrospective Chart Review in Select European Countries

    Nov 1, 2016, 00:00

  • Cadth’s $50,000 Cost-Effectiveness Threshold- Fact or Fiction?

    Nov 1, 2016, 00:00

  • Estimation of The Budget Saving Potential Due To The Introduction of Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Spain

    Nov 1, 2016, 00:00

  • Elements of Orphan Drugs Value

    Nov 1, 2016, 00:00

  • How Assessment Methods May Affect The Efficiency Of Appraisal Process- A Critical Review

    Nov 1, 2016, 00:00

  • clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients with Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Workload Analysis And Staffing Requirement Of Clinical Pharmacy Services At Ministry Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of 52 Mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) Versus Short-Acting Hormonal Contraceptives In Avoiding Unintended Pregnancy (Up) In 15 To 19 Year-Old Adolescents Under The Brazilian Public Health ...

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Edoxaban Compared to Warfarin for The Treatment and Secondary Prevention of Venous Thromboembolism in The UK

    Nov 1, 2016, 00:00

  • Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)

    Nov 1, 2016, 00:00

  • The Public Health And Economic Impact Of Gender Neutral Quadrivalent Human Papillomavirus Vaccination Program In Brazil

    Nov 1, 2016, 00:00

  • Prevalence of Potentially Inappropriate Prescribing in Central Nervous System and Psychotropic Drugs for the Korean Elderly- A Cross-Sectional Study Using the National Health Insurance Claims Database

    Nov 1, 2016, 00:00

  • Market Access Agreements- What Impacts Drugs Purchasing in French Hospitals

    Nov 1, 2016, 00:00

  • Taking In Account Research And Development Expenditures To Determine Prices Of Medicines In Fran A Realistic Alternative Choice?

    Nov 1, 2016, 00:00

  • Comparative Efficacy and Saftey of Interventions in The Treatment of Advanced Soft Tissue Sarcoma- A Systematic Review and Network Meta Analysis

    Nov 1, 2016, 00:00

  • Review of Data Cuts used as Basis for Statistical Analyses and Derivation of Additional Benefit Presented within German Benefit Assessments for Oncological Drugs

    Nov 1, 2016, 00:00

  • Linguistic Validation Of The Finnish Version Of The Visual Analogue Scale Foot And Ankle Instrument

    Nov 1, 2016, 00:00

  • Optimizing COPD Treatment In Portugal – Improving Health Outcomes And Reducing Treatment Costs In Patients with A History of Exacerbation with Indacatrol Plus Glycopyrronium

    Nov 1, 2016, 00:00

  • International Reference Pricing's Evolution In China

    Nov 1, 2016, 00:00

  • What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision Analysis

    Nov 1, 2016, 00:00

  • Adapting to the Challenge- How are Innovative Study Designs Being used in Rare Diseases?

    Nov 1, 2016, 00:00

  • Delayed Access To Bariatric Surgery In Brazil- Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Societal And-Economic Burden of Iron Deficiency Among Swiss Women – Results from a Household Survey

    Nov 1, 2016, 00:00

  • Improving Patients Quality of Life By Valuation of Patient Satisfaction with Specific Characteristics of Medical Devices For Urinary Incontinence

    Nov 1, 2016, 00:00

  • An Observational Study On Helath Related Quality Of Life In Diabetes Mellitus Patients

    Nov 1, 2016, 00:00

  • Impact of Cardiovascular Outcome Trial (CVOT) Data on EU5 Access for New Type 2 Diabetes Drugs

    Nov 1, 2016, 00:00

  • Estimating Study Costs For Use In Voi, A Study Of Dutch Publicly Funded Drug Related Research

    Nov 1, 2016, 00:00

  • Rapid, Comprehensive Oral Nutritional Supplement Quality Improvement Program Reduces Length Of Stay In Malnourished Hospitalized Patients

    Nov 1, 2016, 00:00

  • Valuing Health- Results from the Health Auction Valuation Experiment (HAVE) Study

    Nov 1, 2016, 00:00

  • Network Meta-Analysis of Antidiabetic Treatments Added To Insulin Therapy In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Comparison of Equity Weights of Various Adverse Consequences of Tobacco Use- A Best-Worst Scaling for Two Types of Chinese General Public

    Nov 1, 2016, 00:00

  • Comparative Safety and effectiveness of Carbapenems Versus Alternative Antibiotics for Bacteraemia due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Empirical Therapy- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Comparison Between the EQ-5D-5l and the EQ-5D-3l for General Population in China

    Nov 1, 2016, 00:00

  • Generalising Results from Cost-Effectiveness Analysis- A Comparison of Methods to Account for Covariates

    Nov 1, 2016, 00:00

  • Helping Decision-Makers Visualize Inequities In Health Impact Assessment- Linked Electronic Records, Mortality And Regional Disparities In Portugal

    Nov 1, 2016, 00:00

  • Refining The Path to Personalized Medicine with Psychometric Analysis of Oral Cancer Biomarkers

    Nov 1, 2016, 00:00

  • Long Term Outcome of Couples Undertaking their First IVF/ICSI Attempt- A French Study

    Nov 1, 2016, 00:00

  • Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For Turkey

    Nov 1, 2016, 00:00

  • An Assessment of The Number of Chronic Lymphocytic Leukemia (CLL) Patients Eligible For Front-Line Treatment But Unsuitable For Full-Dose Fludarabine Across The European Union

    Nov 1, 2016, 00:00

  • Patterns of Medication Regimen Complexity Over One-Year Follow Up in Chronic Obstructive Pulmonary Disease Patients

    Nov 1, 2016, 00:00

  • Risk of Discontinuation of Advanced Therapy Medicinal Products Clinical Trials

    Nov 1, 2016, 00:00

  • Innovative Contracting in Spain (2010-2016). Getting More "IN"

    Nov 1, 2016, 00:00

  • Patients’ Preferences Toward Characteristics of Treatment with Biological Agents Differ According to Experience with their Rheumatic Disease and Treatment Received or Prescribed- Results from the Cara Study

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Lipegfilgrastim in Prophylaxis Of Febrile Neutropenia in Cancer Patients

    Nov 1, 2016, 00:00

  • New Approach to Budget Impact Analysis - Ibrutinib In Treatment of Relapsed/Refractory Cll Patients in The Czech Republic

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis in Postoperative Pain Management After Non-Cardiac Major Surgeries in China- Parecoxib Versus Nonselective Nonsteroidal Anti-Inflammatory Drugs and Tramadol

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Internet-Delivered Cognitive Behavior Therapy for Adolescent Obsessive-Compulsive Disorder

    Nov 1, 2016, 00:00

  • A Systematic Review of Treatment Patterns in Patients with Recurrent Glioblastoma in the Real World

    Nov 1, 2016, 00:00

  • Review of National Health Technology Assessment Reports on Treatment of Severe Haemophilia A

    Nov 1, 2016, 00:00

  • Quality of Life in Patients with Total Knee Replacement in Czech Republic

    Nov 1, 2016, 00:00

  • Comparison of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening- A Systematic Review

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Regorafenib for The Treatment in Third and Fourth Lines of Metastasic Colorectal Cancer in Spain

    Nov 1, 2016, 00:00

  • Analyzing a German Index for the EQ-5D-5L Based on Experienced Health

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Dabigatran vs. Rivaroxaban and Vitamin K Antagonists in Elderly Patients with Nonvalvular Atrial Fibrillation in Spain

    Nov 1, 2016, 00:00

  • Cost Comparison of Wet Age-Related Macular Degeneration Treatment with Aflibercept or Ranibizumab

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of A Flash Glucose Monitoring System for Patients with Diabetes Who Are Using Intensive Insulin

    Nov 1, 2016, 00:00

  • High-Risk Medications and Unplanned Hospitalizations- A Case–Time–Control Study

    Nov 1, 2016, 00:00

  • The Risks of Using Chinese Medications Associated with Cardiovascular Disease, Diabetes Mellitus, and Chronic Kidney Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Real-World Evidence on Healthcare Resource use and Associated Cost With Multiple Myeloma in The Netherlands

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients with Chronic Hepatitis C Virus Genotype 1 in Iran

    Nov 1, 2016, 00:00

  • Linguistic Validation and Electronic Migration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)

    Nov 1, 2016, 00:00

  • Impact Of The Introduction Of New Branded Generic Equivalents On The Prescribing Patterns Of Anti-Dementia Medication

    Nov 1, 2016, 00:00

  • The Morphological Study of Human Brown Adipose Tissue During Fetal Development

    Nov 1, 2016, 00:00

  • Effects of Medical Marijuana Legalization on Marijuana Use Among Adolescents and Adults In The United States

    Nov 1, 2016, 00:00

  • Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm)

    Nov 1, 2016, 00:00

  • A Qualitative Study Evaluating The Attitude and Perception of Physician and Pharmacist Towards Pharmacovigilance in Abbottabad, Pakistan

    Nov 1, 2016, 00:00

  • Disease Severity and Control in Adults with a History of Moderate to Severe Atopic Dermatitis- Results from a Large Patient-Physician Survey in the United Kingdom, Germany, and France

    Nov 1, 2016, 00:00

  • Indirect Comparison of Triamcinolone Acetonide with Ranibizumab and Aflibercept for the Treatment of Diabetic Macular Edema

    Nov 1, 2016, 00:00

  • Cardiovascular Event Rates in Patients with High Cardiovascular Risk in the United Kingdom

    Nov 1, 2016, 00:00

  • Dengue Negatively Affects Gdp And Federal Revenues In Endemic Areas Of Mexico

    Nov 1, 2016, 00:00

  • Is Early Initiation of Biologic Treatment more Effective than a Step up Treatment Approach for New Onset Juvenile Idiopathic Arthritis?-- using a Causal Inference Approach to Achieve a Double Robust Estimate

    Nov 1, 2016, 00:00

  • 1) Value of The Clinical Decision Support System For Adverse Drug Event Prevention- A Cost-Effectiveness Analysis And Cost-Benefit Analysis

    Nov 1, 2016, 00:00

  • Faecal Calprotectin as A Diagnostic Marker of Inflammatory Bowel Disease in Patients with Gastrointestinal Symptoms - is It Cost-Effective Procedure in Primary Care in Poland?

    Nov 1, 2016, 00:00

  • Assessing The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In France, Italy And Sweden

    Nov 1, 2016, 00:00

  • Follow-Up Analysis Of Validity Of Bia For Drugs Temporarily Reimbursed In Mode Of Coverage With Evidence Development

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Evaluation of Patients Undergoing Hemodialysis At a Tertiary Care Centre

    Nov 1, 2016, 00:00

  • Expert Elicitation- Can Variation In Elicited Distributions Be Explained By Expert Heterogeneity?

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of The Use Of Infliximab Biosimilar Inflectra In Rheumatoid Arthritis, Psoriatic Arthropathy And Ankylosing Spondylitis Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Ticagrelor 60 Mg in High-Risk Post-Mi Patients From A Dutch Societal Perspective

    Nov 1, 2016, 00:00

  • Parametric Simulation of Headache Day Frequency Using A Negative Binomial Distribution- A Case Study of Erenumab in Episodic Migraine

    Nov 1, 2016, 00:00

  • Economic Evaluations of Haemophilus Influenzae Type B Vaccine- A Systematic Review

    Nov 1, 2016, 00:00

  • Price Negotiations for Orphan Drugs in Germany

    Nov 1, 2016, 00:00

  • Health Insurance Cost of Mental and Behavioural Disorders Due to Psychoactive Substance Use in Hungary- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • Clinico-Economic Evaluation of Combined Treatment of Diabetic Macular Edema

    Nov 1, 2016, 00:00

  • Empirical Assessment of the Impact of Model Choice (Markov State Transition Versus Partitioned Survival) in Modelling Small-Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Could European Regulators Contribute to Drug Budget Containment?

    Nov 1, 2016, 00:00

  • Assess the Medication Adherence in Patients with Severe Mental Illness Attending Public Tertiary Care Hospitals of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Health Resources Use In Patients With Human Immunodeficiency Virus (Hiv) Infection. Real world evidence from italian administrative databases

    Nov 1, 2016, 00:00

  • Multimorbidity and Health Care Service Utilization in the Australian Workfor Findings From the National Health Survey

    Nov 1, 2016, 00:00

  • Economic Burden of Antibiotic-Resistant Nosocomial Gram-Negative Infections in Singapore Hospitals

    Nov 1, 2016, 00:00

  • Development of Hospital Formulary in Japan - Current Trends and Issues

    Nov 1, 2016, 00:00

  • Market Access Routes for Orphan Oncology Drugs- How do Health Systems Help Patients Receive Treatments that are not Cost-Effective?

    Nov 1, 2016, 00:00

  • Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Economic Study of Non-Pharmacological and Pharmacological Treatment for Osteoporosis Vertebral Fracture and Bone Events in Oncology Patients in a Health Insurance Provider in a Latin America Country

    Nov 1, 2016, 00:00

  • Effectiveness of Antiviral Therapy for Genotype 1 Chronic Hepatitis C in Real-World Patients from the Valencian Community (Spain)

    Nov 1, 2016, 00:00

  • The Quality-Adjusted Time Without Symptoms and Toxicity (Q-TWIST) in (IMMUNO)-Oncology- A Systematic Review of the Literature

    Nov 1, 2016, 00:00

  • Long-Term Health Care Cost in Patients with Symptomatic Peripheral Artery Disease- Results from a Swedish Nationwide Study

    Nov 1, 2016, 00:00

  • Gefitinib, Erlotinib and Chemotherapy as Second-Line Treatment for Patient with Advanced Non-Small Lung Cancer (NSCLC)

    Nov 1, 2016, 00:00

  • Effect of CVD on COPD Related Resource Utilization and Direct Medical Costs Among Statutory Heatlh Insured Patients In Germany

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation And Cost Of Parkinson’s Disease In The United Kingdom

    Nov 1, 2016, 00:00

  • Psychometric Evaluation Of The Revised Hiv Treatment Satisfaction Questionnaire (Hivtsq)

    Nov 1, 2016, 00:00

  • The Clinical, Functional and Economic Benefits of Physical Rehabilitation- A Systematic Review

    Nov 1, 2016, 00:00

  • The Intergenerational Transmission of Adiposity Across Countries

    Nov 1, 2016, 00:00

  • From The Unified Parkinson’s Disease Rating Scale (UPDRS) To The EQ-5D Utility Index- Development of A New Mapping Algorithm In Parkinson’s Disease (PD)

    Nov 1, 2016, 00:00

  • Economic Burden of Diseases In Poland

    Nov 1, 2016, 00:00

  • Developing a Comprehensive, Culturally Sensitive Conceptual Framework of Health Domains in Singapore

    Nov 1, 2016, 00:00

  • Predicted Demand For A New Injectable Solution For Delivering Glaucoma Medicine

    Nov 1, 2016, 00:00

  • Predictors of Response to Interferone/Ribavarin Combination Therapy in Chronic Hepatitis C Virus Infection at Upper Egypt

    Nov 1, 2016, 00:00

  • Development, Validation, and Pilot Testing of Metabolic Syndrome Quality of Life Questionnaire (Tapmetsqol)

    Nov 1, 2016, 00:00

  • Treatment Persistence with Golimumab in France

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Resource Utilization and Costs Associated with the Investigation of Pulmonary Nodules in Quebec, Canada

    Nov 1, 2016, 00:00

  • Health Economic Costing Methods and Reporting in Austria

    Nov 1, 2016, 00:00

  • Cancer Concerns From US Medical And Pharmacy Directors 2016

    Nov 1, 2016, 00:00

  • Assessment of A Pilot Program on Cervical Cancer Screening Carried out By Health Visitors In Hungary

    Nov 1, 2016, 00:00

  • Economic Evaluation of First Line Treatment for Advanced Non Small Cell Lung Cancer Using Tyrosine Kinase Inhibitors in Malaysia

    Nov 1, 2016, 00:00

  • Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For France, Germany, Italy, Spain And United Kingdom

    Nov 1, 2016, 00:00

  • Insights Into Early Stages of Alzheimer's Disease Using Claims Data

    Nov 1, 2016, 00:00

  • Economic Burden of Anti-Methicillin-Resistant Staphylococcus Aureus (Mrsa) Therapy in Public Hospitals of Paris (Ap-Hp) and Adequacy with the Defined Daily Doses

    Nov 1, 2016, 00:00

  • Use of Antihypertensive Medications in Diabetic and Non-Diabetic Chronic Kidney Disease and Hemodialysis Patients- A Due Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Insulin Degludec Compared with Insulin Glargine in the Management of Type 1 and Type 2 Diabetes Mellitus from the Spanish National Health System Perspective

    Nov 1, 2016, 00:00

  • Masters Degrees For Health Economists- Investigating And Evaluating Their Content

    Nov 1, 2016, 00:00

  • Improving Access to new Oncology Drugs in the China Market- Shortentime-To-Market and Improve Affordability

    Nov 1, 2016, 00:00

  • Economic Burden of Primary Immunodeficiency (PIDD) In Turkey

    Nov 1, 2016, 00:00

  • Costs of Multiple Myeloma Management And Treatment For Elderly Patients Who Are Not Transplant Candidates In The Serbian Health Care System

    Nov 1, 2016, 00:00

  • A Cost of Illness Study Evaluating The Healthcare And Societal Burden of Friedreich’s Ataxia In The United Kingdom

    Nov 1, 2016, 00:00

  • Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nepafenac 3 Mg/Ml for the Reduction in Risk of Post-Operative Macular Oedema Associated with Cataract Surgery- From UK NHS Perspective

    Nov 1, 2016, 00:00

  • Dispensing Patterns of Vaccines by Pharmacies in South Africa

    Nov 1, 2016, 00:00

  • Criteria Used by German Pulmonologists for the Selection of an Inhaler

    Nov 1, 2016, 00:00

  • Evaluating Factors Associated with Depressive Symptoms Among Postpartum Mothers in South Punjab, Pakistan

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications

    Nov 1, 2016, 00:00

  • Conceptual Model and Clinical Outcomes Assessments for Angelman’s Syndrome- Utilizing Pragmatic Methods in Rare Diseases

    Nov 1, 2016, 00:00

  • Asians' Mental Health Status in a u.s. Midwestern metropolis, 2004 -2013

    Nov 1, 2016, 00:00

  • Health Care Direct Cost Burden of Diabetes in Medicare Beneficiaries With Obesity

    Nov 1, 2016, 00:00

  • Global Value Dossiers (GVDS)- How to Ensure the Value Isn’t Lost in Translation

    Nov 1, 2016, 00:00

  • The Number Of Cases In Physiotherapy Services Within Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • Meta-Analysis of The Effectiveness on Peginterferon for Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Herpes Zoster-Associated Resources Consumption In Chronic Obstructive Pulmonary Disease Patients

    Nov 1, 2016, 00:00

  • Treatment Pattern Differences Across the United States, Western Europe, and Japan Among Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Country Trends that May Impact the Commercial Opportunity of New High Cost Treatments in the USA, EU5, Japan and Brazil

    Nov 1, 2016, 00:00

  • Real-World Comparing Intravenous Busulfan to Total Body Irradiation in Hematopoietic Stem Cell Transplantation aith a Japanese Diagnosis Procedure Combination (DPC) Database

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The Permanent Endovascular Adhesive Closure System in The Treatment of Venous Reflux and Chronic Venous Insufficiency (CVI) in Turkey

    Nov 1, 2016, 00:00

  • Economic Aspects in the Treatment of Schizophrenia in Italy- Cost Consequences of an Early Long-Acting Injectable Antipsychotics (LAIS) Approach

    Nov 1, 2016, 00:00

  • Health Technology Assessment Considerations of The Primary Care Model Programme

    Nov 1, 2016, 00:00

  • community Residents' Knowledge and Attitudes Towards Antibiotics in Penang, Malaysia- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • Analysis of the Relationship Between Blood Pressure in Health Checkup and Effectiveness of Antihypertensives

    Nov 1, 2016, 00:00

  • Which costs matter? Costs included in economic evaluation and their impact on decision uncertainty- the example of acute myocardial infarction

    Nov 1, 2016, 00:00

  • Translatability Evaluation of the Rome IV Diagnostic Questionnaire for Adults

    Nov 1, 2016, 00:00

  • Assessment of Race-Specific Tolerability And Effectiveness of Exenatide once-Weekly or Basal Insulin Among Patients With Type 2 Diabetes In A Real World Setting In The USA

    Nov 1, 2016, 00:00

  • Economic Evaluation for the United Kingdom of Systemic Chemotherapies as First-Line Treatment for Metastatic Pancreatic Cancer

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Once-Yearly Injection of Zoledronic Acid For The Treatment of Osteoporosis In Japan

    Nov 1, 2016, 00:00

  • Oncologists` Views on Reimbursement and Value of Cancer Drugs in Bosnia and Herzegovina

    Nov 1, 2016, 00:00

  • Investigating The Perceptions Of The Greek Population Towards The Efficacy And Safety Of Generic Drugs

    Nov 1, 2016, 00:00

  • The Association of Adherence to Disease-Modifying Drugs and Out-of-Pocket Costs in Patients with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Assessment of Proton Pump Inhibitors Consumption in Ukraine in Comparison with other Countries of The World

    Nov 1, 2016, 00:00

  • Gefitinib, Erlotinib or Afatinib for EGFR Mutated NSCLC patients? A Meta-Analysis and Indirect Comparison on the Efficacy of First-Line Tyrosine Kinase Inhibitors

    Nov 1, 2016, 00:00

  • Excess Costs of Panic Disorder with or without Agoraphobia in Germany - The Application of Entropy Balancing to Multiple Imputed Datasets

    Nov 1, 2016, 00:00

  • Reviewing the Economic Impact of Extending the National Immunization Program in Egypt

    Nov 1, 2016, 00:00

  • Assessing The Potential Cost Saving Potential of Implementing Benepali®, An Etanercept Biosimilar, Using Discount Agreements For The Treatment of All Licensed Etanercept Indications For Adults In Sweden

    Nov 1, 2016, 00:00

  • Products Outside the General Reimbursement Systems – A Swedish and Norwegian Comparison

    Nov 1, 2016, 00:00

  • Copd Uncovered- Health Care Resource Use and Cost of Chronic Obstructive Pulmonary Disease in Japan

    Nov 1, 2016, 00:00

  • Implication Of External Price Referencing On Pharmaceutical List Prices In Europe

    Nov 1, 2016, 00:00

  • The Organisational Analysis of “Patient Diagnostic Therapeutic Pathway” For Patients with Gastric Cancer In 5 Centres of The Veneto Region (Italy)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Diagnostics of Tuberculosis Infection in The Russian Federation with The Use of Tuberculous Recombinant Allergen

    Nov 1, 2016, 00:00

  • Comparative Analysis on The Out-Of-Pocket Expenditure Among Patients Suffering From Chronic Kidney Disease between Medical Insurance Covered And Uncovered Areas in China

    Nov 1, 2016, 00:00

  • Have Budget Impact Analyses Included Clinical Outcomes?

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilization in Patients Receiving Pembrolizumab or Docetaxel with Previously Treated Advanced NSCLC

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Intravitreal Aflibercept (IVT-AFL) in Treatment of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO)

    Nov 1, 2016, 00:00

  • Implementation of Medication Errors Reporting System by Clinical Pharmacists at Tertiary Care Teaching Hospital- A Pilot Study

    Nov 1, 2016, 00:00

  • Prospective Study of the Incidence, Nature and Causes of Dispensing Errors in Community Pharmacies of Ulaanbaatar, Mongolia

    Nov 1, 2016, 00:00

  • A Conceptual Framework for Tackling Market Access Challenges in Asia

    Nov 1, 2016, 00:00

  • Prevalence of Obesity And Overweight And Associated Factors Among Financial Institution Workers In Accra Metropolis, Ghana- A Case Control Study

    Nov 1, 2016, 00:00

  • The Validity of Markov Model for the Prognostic Estimation of Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Economic Evaluation of Olaparib In Patients with Brca – Mutated Psroc in Greece

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Perception of Japanese Encephalitis Among Healthcare Students of Medicine, Pharmacy and Dentistry of A Private University in Malaysia

    Nov 1, 2016, 00:00

  • Using Simulated Individual Patient Data (IPD) From Published Registry and Ipd From The Seer-Medicare Registry To Extrapolate Results From Randomised Clinical Trials (RCTS) in Metastatic Melanoma

    Nov 1, 2016, 00:00

  • Impact of Empagliflozin (Jardiance) to the NHS- Estimation of Budget and Event Impact Based on Empa-Reg Outcome Data

    Nov 1, 2016, 00:00

  • Psychometric Validation of Anti-Clot Treatment Scale in Japanese Patients with Atrial Fibrillation

    Nov 1, 2016, 00:00

  • The German Pain Practice Registry – A New Way to Use Real-Time Sampled Routine Data For Health-Care Research

    Nov 1, 2016, 00:00

  • Historical and Future Oral Lipid Modifying Therapy Market Size in Top Five European Countries

    Nov 1, 2016, 00:00

  • Indirect Costs Of Epilepsy In Turkey- Cost Of The Disease In Terms Of Work Loss

    Nov 1, 2016, 00:00

  • Etiology and Outcome of Acute Kidney Injury in South Indian Population

    Nov 1, 2016, 00:00

  • Association Between Insulin Treatment and Breast Cancer Characteristics

    Nov 1, 2016, 00:00

  • Economic Impact of Drug Addiction Interventions in Adult Population- The Peru Case

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Restricted Protein Diet In Patients With Phenylketonuria In The Czech Republic

    Nov 1, 2016, 00:00

  • Assessing The Economic Burden of Heart Failure in Korea- Incremental Cost Approach

    Nov 1, 2016, 00:00

  • Market Uptake Of Direct Oral Anticoagulants (Doacs) In Germany

    Nov 1, 2016, 00:00

  • Development Of A Search Engine For The Medline Database With Search Results Ranking From The Perspective Of Evidence-Based Medicine

    Nov 1, 2016, 00:00

  • Determening The Optimal Price For New Non-Nucleoside Reverse Transcritase Inhbitor Using Early Economic Modeling

    Nov 1, 2016, 00:00

  • Measuring Caregiver Quality of Life; Which Aspects Really Matter?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Endoscopic Treatment with Radiofrequency Ablation for Patients with Barrett's Esophagus and High Or Low Grade Dysplasia in Spain

    Nov 1, 2016, 00:00

  • Adding A Decision Aid to Asthma Education- Impact on Decisional Conflict and Appropriate Medication Usage

    Nov 1, 2016, 00:00

  • Inclusion Of Costs And Effects Related To Toxicity/Safety In Cost -Effectiveness Analysis; An Illustration For Influenza Vaccines

    Nov 1, 2016, 00:00

  • The Evpi of Treatment Strategies for Radioiodine-Refractory Differentiated Thyroid Cancer

    Nov 1, 2016, 00:00

  • Direct Cost Analysis and Cost Effectiveness Analysis of Chronic Obstruction Pulmonary Disease in Fatmawati Public Hospital

    Nov 1, 2016, 00:00

  • Three Year Treatment Patterns of Ranibizumab and Aflibercept for The Management of Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in The USA

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Sunitinib Versus Pazopanib and Best Supportive Care for the Treatment of Metastatic Renal Cell Carcinoma in Chile

    Nov 1, 2016, 00:00

  • Economic Consequences of The Determinalistic Relation Between Laboratory Tests Indication And Antibiotic Prescription

    Nov 1, 2016, 00:00

  • The Use of The Appraisal of Guidelines for Research and Evaluation Ii (AGREE II) Tool for Appraisal of Multiple Myeloma Treatment Guidelines

    Nov 1, 2016, 00:00

  • Obstacles for Adoption of Value Added Medicines- Call for Policy Changes for Value Recognition of Repurposed Medicines

    Nov 1, 2016, 00:00

  • Indirect Costs of Stroke in Turkey

    Nov 1, 2016, 00:00

  • Managing Effective Access To Biosimilars- In Search Of An Optimal Framework For Catalonia

    Nov 1, 2016, 00:00

  • Efficacy and Safety of Panitumumab in Patients of Metastatic Colorectal Cancer By Tumor Kras Status- A Systematic Review

    Nov 1, 2016, 00:00

  • Challenges in Economic Evaluations Conducted Alongside Clinical Trials of Schizophrenia- The Case of the Actions Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Implementing Computed Tomography Screening for Early Diagnosis of Lung Cancer in Taiwan

    Nov 1, 2016, 00:00

  • Evaluation of Sulphonylurea Induced Cardiovascular Events in Diabetic Patients in Comparison with Non Sulphonylurea at South Indian Teaching Hospital

    Nov 1, 2016, 00:00

  • Generic Drug Volume and Cost Savings in Oncology- A 2005-2014 Midas Analysis

    Nov 1, 2016, 00:00

  • Determination of Predictors of Prolonged Hospitalization among Dengue Patients Attending Tertiary Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of A Flash Glucose Monitoring System for Type 1 Diabetes (T1DM) Patients Receiving Intensive Insulin Treatment in Europe and Australia

    Nov 1, 2016, 00:00

  • Healthcare Costs Among Multiple Myeloma (MM) Patients (PTS) without Stem Cell Transplant (SCT)

    Nov 1, 2016, 00:00

  • Association Between Exposure To Anticholinergic And Sedative Drugs And Healthcare Costs In Elderly Patients With Cognitive Complaint

    Nov 1, 2016, 00:00

  • Comparative Efficacy of Reslizumab and Mepolizumab For The Treatment of Asthma- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Funding Expensive Drugs In Hospitals- Where Is France Going?

    Nov 1, 2016, 00:00

  • Economic Impact of Rivaroxaban use for Thromboembolic Events Prevention After HIP or Knee Replacement in Spain

    Nov 1, 2016, 00:00

  • The Implications of Parameter Independence in Probabilistic Sensitivity Analysis

    Nov 1, 2016, 00:00

  • Iron Deficiency Anemia In Pregnant Women In Fran A Prospective Cohort Study

    Nov 1, 2016, 00:00

  • 3 Year Clinical Effectiveness of Ranibizumab And Aflibercept For Neovascular AMD- A Retrospective Cohort Study Using Electronic Medical Records From The USA

    Nov 1, 2016, 00:00

  • Forecasting Lifetime Health Outcomes and Costs of Treatment for Non-Alcoholic Fatty Liver Disease

    Nov 1, 2016, 00:00

  • Patient-Reported Need vs. Concern Around Injectable Therapy and Impact on Adheren A Real-World Survey of 5EU/US T2DM Patients

    Nov 1, 2016, 00:00

  • Estimating the Appropriate Price Discounts for Biosimilars in the Treatment of Rheumatoid Arthritis in the Nordic Setting Using an Excel-Based Interactive Tool

    Nov 1, 2016, 00:00

  • Biosimilars- Which Value For Society?

    Nov 1, 2016, 00:00

  • Could Amnog Become Irrelevant in the 21st century? Potential Redundancies in The Amnog Process in the ERA of Curative Therapies

    Nov 1, 2016, 00:00

  • Azacitidine for Treating Acute Myeloid Leukaemia- A Nice Single Technology Appraisal

    Nov 1, 2016, 00:00

  • Cost-Utility of Prophylaxis VS. On-Demand Treatment In Severe Haemophilia A Patients

    Nov 1, 2016, 00:00

  • Complete Skin Clearance Is Not Attained By Most Patients Receiving Biologics For Moderate To Severe Plaque Psoriasis- Interim Results of An International, Prospective, Observational Study

    Nov 1, 2016, 00:00

  • A New Accelerated Early Access Process for Diagnostics in France

    Nov 1, 2016, 00:00

  • Disease Activity, Quality of Life And Indirect Costs Associated With Ulcerative Colitis In Poland

    Nov 1, 2016, 00:00

  • Comparison Of Estimated Effectiveness Of Biologics For Rheumatoid Arthritis (Ra) In Large Insurance Databases Using A Claims-Based Algorithm

    Nov 1, 2016, 00:00

  • Ovarcost Study- Economic Burden of Epithelial Ovarian Cancer in Spain

    Nov 1, 2016, 00:00

  • Estimating the contribution on the reduction of the burden of iron deficiency anemia from the current fortification strategy of commercial foods targeted to infants and toddlers in india. Scenarios using systematic review and real world evi ...

    Nov 1, 2016, 00:00

  • Network Analysis Approach To Explore Sponsor Involvement In Clinical Trials

    Nov 1, 2016, 00:00

  • Prescribing Patterns of Opioids Dispensed by Pharmacies in South Africa

    Nov 1, 2016, 00:00

  • Comparison of Mortality Reduction From Gastric Cancer Among Different Screening Programs

    Nov 1, 2016, 00:00

  • A Comparative Cost Analysis on Peritoneal Dialysis Versus Hemodialysis in Taiwan

    Nov 1, 2016, 00:00

  • Online Pharmacy Regulation in India- A Cross Sectional Survey on Perceptions of Health Care Students/Professionals

    Nov 1, 2016, 00:00

  • Risk and Burden of Subsequent Fractures After First Osteoporosis-Related Fracture Among Osteoporosis Patients in Tianjin, China

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Adding Novel or Group 5 Interventions To A Background Regimen For The Treatment of Multidrug-Resistant Tuberculosis In Germany

    Nov 1, 2016, 00:00

  • The Potential to Improve Inhalation Technique in Patients with Asthma Or Copd By Switching From Symbicort® Turbuhaler® (Budesonide + Formoterol) to Duoresp® Spiromax®- Estimated Impact on The Number and Cost of Unscheduled Healthcare Events ...

    Nov 1, 2016, 00:00

  • Seasonal Variations of Outpatient Antibiotic use in Austria

    Nov 1, 2016, 00:00

  • Bariatric Surgery Versus Non-Surgical Treatment of Morbid Obesity- A Systematic Review

    Nov 1, 2016, 00:00

  • Quinolones Utilization in Two Tertiary Hospitals in Nigeria; A Pharmacoepidemiological Survey

    Nov 1, 2016, 00:00

  • Results From An on-Site Healthcare Provider Survey on Perceptions of Type 2 Diabetes Treatment

    Nov 1, 2016, 00:00

  • Health Technology Assessment Decisions for Novel Psoriasis and Psoriatic Arthritis Agents- Results, Rationale, and Trends

    Nov 1, 2016, 00:00

  • Identifying Potential Early Biomarkers Of Acute Myocardial Infarction In The Biomedical Literature- A Comparison Of Text Mining And Manual Sifting Techniques

    Nov 1, 2016, 00:00

  • Economic Evaluation of Pertuzumab In Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment of Women with HER2-Positive, Locally Advanced, Inflammatory or Early Breast Cancer in Portugal

    Nov 1, 2016, 00:00

  • Title- Access to Orphan and Ultra-Orphan Drugs in China

    Nov 1, 2016, 00:00

  • Linguistic Validation of the Finnish Version of the Body-Q Pro Instrument

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden of Heart Failure Patients in Korea

    Nov 1, 2016, 00:00

  • Knowledge, Attitude And Perception Of Zika Virus Among Healthcare Students Of Medicine, Pharmacy And Dentistry Of Aimst University

    Nov 1, 2016, 00:00

  • Pretesting An E-Based Version Of The Oxford Participation Activities Questionnaire (Ox-Paq)

    Nov 1, 2016, 00:00

  • A Synopsis on Opportunities and Challenges of Patient Related Outcome Measures (PROMS) for Patient Benefits

    Nov 1, 2016, 00:00

  • How Much Does An Asthma-Related Event Cost In A Malaysian Suburban Hospital?

    Nov 1, 2016, 00:00

  • Knowledge, Attitudes and Practices of Cervical Cancer Screening Among Women Attending A Childhood Immunization Clinic in Uganda

    Nov 1, 2016, 00:00

  • Creating Useful and Comprehensive Decision Support Tools for Selecting and Designing Managed Entry Agreements

    Nov 1, 2016, 00:00

  • A Population-Based Cohort of Gaucher Disease Patients Identified Using EHR Data

    Nov 1, 2016, 00:00

  • Implementation of Adverse Event Trigger Tool System for Assessing Patient Safety

    Nov 1, 2016, 00:00

  • Budget Impact of Switching From an Extended-Release to an Immediate-Release Formulation of Tacrolimus in Renal Transplant Recipients in Spain

    Nov 1, 2016, 00:00

  • Does The Trend Towards Value Frameworks Require New Approaches to Evidence Development and Health Technology Assessment?

    Nov 1, 2016, 00:00

  • New Legislative Pathway of Turkey for Assessing Reimbursement Applicatons of Medical Devices

    Nov 1, 2016, 00:00

  • Viewpoints of Thalassaemia Patients on the Combination of Traditional CM) with the Conventional Thalassaemia Treatment-A Qualitative Understanding Approach

    Nov 1, 2016, 00:00

  • Modelling Total Knee Replacement Surgery For Osteoarthritis in New Zealand- Validation of A Population-Based State-Transition Microsimulation Model

    Nov 1, 2016, 00:00

  • Hospital Admissions and Inpatient Costs of Non-Union, Delayed Union and Mal-Union Following Long Bone Fracture

    Nov 1, 2016, 00:00

  • Optimal and Ensure Trials - Based Combined Cost-Effectiveness Analysis of Erlotinib Versus Chemotherapy for the First- Line Treatment of Asian Patients with Nonsquamous Non– Small-Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Horizontal and Vertical Financial Equity in Hospitalized Cardiovascular Patients; A Case Study in Iran

    Nov 1, 2016, 00:00

  • A Comparison of Euroqol EQ-5D And SF-36 for Estimating Health-Adjusted Life-Expectancy (HALE) in Taiwan

    Nov 1, 2016, 00:00

  • Influence of Air Pollution on Some Pregnancy Outcomes and Burden of Pneumonia on Children Under Five Years Old in Mongolia

    Nov 1, 2016, 00:00

  • Application of Payment by Results Schemes in Oncology in Italy- Relation Between Timing for the Evaluation of Treatment Failures and Median Progression Free Survival (PFS) from Clinical Trials

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Population Screening for Haemochromatosis In Australia- A State-Transition Model

    Nov 1, 2016, 00:00

  • Instructions for Authors

    Nov 1, 2016, 00:00

  • How do Cost-Containment Measures Impact Pharmaceutical Industry?

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis To Access The Efficacy and Safety of Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

    Nov 1, 2016, 00:00

  • Evaluate the Cost-Effective Threshold of Osteoporosis Treatment on Elderly Women in China Using Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Procalcitonin-Based Antibiotics Stewardship for Community Acquired Pneumonia

    Nov 1, 2016, 00:00

  • Cost of Switching From An Originator Biologic (Remicade) To A Biosimilar

    Nov 1, 2016, 00:00

  • A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness

    Nov 1, 2016, 00:00

  • Lipid Levels and Glycaemic Control in Malaysian Diabetes Patients

    Nov 1, 2016, 00:00

  • Direct and Indirect Costs Associated with Legal Blindness Caused by Retinal Disorders in Brazil

    Nov 1, 2016, 00:00

  • Assessment of Knowledge, Attitude and Barriers Towards ADRS Reporting Among Healthcare Professionals of Abbottabad, Pakistan

    Nov 1, 2016, 00:00

  • Productivity Loss In Patients Diagnosed With Spinal Stenosis And Lumbar Disc Herniation

    Nov 1, 2016, 00:00

  • Presence of Lipohypertrophy and its Relation to Insulin Injection Practices in Patients with Type 1 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Health Expenditure By Disease Age And Gender In Greece

    Nov 1, 2016, 00:00

  • The Budget Impact Analysis of Thrombopoietin Receptor Agonists For The Treatment of Idiopathic Thrombocytopenic Purpura In Adults

    Nov 1, 2016, 00:00

  • Ongoing Analysis of Clinical and Economic Outcomes of Japanese Patients with Coronary Heart Disease Undergoing Percutaneous Coronary Intervention

    Nov 1, 2016, 00:00

  • Trends in Research Using Observational Methodologies in Chronic Lymphocytic Leukemia (CLL)- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Relationship between Perception of Sex Hormones Imbalance, Depression and Cognitive Function among Female Students in International Medical University- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • Real-World Evidence in the Context of Hta- On the Example of Uterine Fibroids Treatment in Ukraine

    Nov 1, 2016, 00:00

  • Pro Instruments for Mental Disorders Used in Studies Published Since 2005- Which Diseases have Had The Most Tools Developed?

    Nov 1, 2016, 00:00

  • Health Outcomes Related to Legal Blindness Caused By Retinal Disorders in Brazil

    Nov 1, 2016, 00:00

  • Market Uptake Models Of Biosimilars And Off-Patent Biological Medicines

    Nov 1, 2016, 00:00

  • Assessment of Secondary Recurrence of Stroke in Aspirin-Clopidogrel Combination Therapy and Aspirin Monotherapy in Transient Ischemic Attack Patients in South India- A Comparative Study

    Nov 1, 2016, 00:00

  • Derivation and External Validation of an Early Readmission Risk Prediction Model

    Nov 1, 2016, 00:00

  • Pay For Performan A Proposal For And Simulation Of Real Time Outcomes-Based Pharmaceutical Pricing Using Routinely Collected Data

    Nov 1, 2016, 00:00

  • The Economic Burden of Fibromyalgia in Japan

    Nov 1, 2016, 00:00

  • The Impact of Different Gastrointestinal Symptoms on The Well-Being of Affected Patients - Utility Weights for The Gastrointestinal Symptom Score (GIS)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Treatment for Recurrent Malignant Glioma in Romania

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Ketoconazole Versus Metyrapone for the Treatment of Cushing’s Syndrome in a Swedish Setting

    Nov 1, 2016, 00:00

  • A Cost-Consequence Analysis of Parecoxib Plus Opioids Versus Opioids Alone In The Management of Postoperative Pain In China

    Nov 1, 2016, 00:00

  • Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in Fran Next Generation Sequencing

    Nov 1, 2016, 00:00

  • Measures of Clinical Benefit in Immuno-Oncology Studies

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Guanfacine Extended-Release Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder

    Nov 1, 2016, 00:00

  • Insights for Care- The Healthcare Utilisation and Cost Impact of Managing Diabetes-Associated Nephropathy and Neuropathy at a UK Secondary Care Hospital

    Nov 1, 2016, 00:00

  • Developing a Geospatial Web and Mobile Application to Improve Expanded Program on Immunization in Ghana- A Mhealth Technology Novelty, 2015

    Nov 1, 2016, 00:00

  • Systematic Review and Network Meta-Analysis (Nma) in Reimbursement Submission; What Nice Says Versus what Nice Wants

    Nov 1, 2016, 00:00

  • Impact of Initiation of Long-Acting Injectable Antipsychotics on Resource Utilization In Patients with Schizophrenia

    Nov 1, 2016, 00:00

  • The Association with Psychiatric Diseases and Patients with Chronic Spontaneous Urticaria in Taiwan

    Nov 1, 2016, 00:00

  • Impact Of Post-Inscription Studies On Reassessment In Fran A Case Study On Orphan Drugs

    Nov 1, 2016, 00:00

  • Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents- An Exploratory Evaluation using Advanced Hierarchical Network Meta-Analysis Techniques

    Nov 1, 2016, 00:00

  • Trends in Health Technology Assessments since the Introduction of Cost-Effectiveness in the Netherlands

    Nov 1, 2016, 00:00

  • Assessing the Gap Between Prioritized Conditions and Covered Conditions in Current Legislation for Rare and Orphan Diseases in Peru

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74 (current)
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »